Pharmaceutical Technology, BioPharma Outsourcing Innovation, February 2022

Ensuring reliable analytical methods and bioassays requires a well-thought-out strategy for evaluating method validity and systems suitability.

Experience is an invaluable asset for outsourcing partners, particularly as more challenging method development services are in demand.

Demand for outsourced services of technical R&D activities is increasing.

Recent news surrounding CDMOs provides insight into ongoing trends in the sector.

A key benefit for companies when outsourcing formulation development is the broad experience they can gain from a dedicated service provider, particularly for niche markets.

Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource.

Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models.

CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.

CDMOs offer expertise and capacity for spray drying.

CDMOs offer expertise and customization options for sponsors of orphan drugs.